US Broker Ratings

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 29% Potential Upside Amidst Market Volatility

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, presents an intriguing investment opportunity for those willing to navigate its current market fluctuations. With a market capitalization of..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Its 6.53% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is making waves in the healthcare sector, particularly the medical devices industry. With a market capitalization of $19.26 billion, the company stands as a..

Waters Corporation (WAT) Stock Analysis: Revenue Growth Soars Over 113% Amid Strategic Expansion

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure to the burgeoning analytical..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 17% Upside Potential in the Healthcare Sector

Investors looking for opportunities in the healthcare sector would do well to consider Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the medical devices industry. With a market capitalization..

Mettler-Toledo International, Inc. (MTD): Stock Analysis Reveals 5.28% Potential Upside in Diagnostics & Research Sector

For investors looking to delve into the healthcare sector, Mettler-Toledo International, Inc. (NYSE: MTD) represents a compelling opportunity within the diagnostics and research industry. Headquartered in Greifensee, Switzerland, this company,..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 21.82% Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to capture investor attention with its robust market position and promising growth prospects. With a market capitalization of..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a 16% Upside Potential

Cencora, Inc. (NYSE: COR), a major player in the healthcare sector, has captured the attention of investors with its strategic positioning in the medical distribution industry. With a market cap..

Bristol-Myers Squibb (BMY) Investor Outlook: Navigating Healthcare Growth Amidst Mixed Ratings

Bristol-Myers Squibb Company (NYSE: BMY) stands as a significant player in the healthcare sector, specifically within the general drug manufacturing industry. With a robust market capitalization of $136.88 billion, this..

Eli Lilly (LLY) Investor Outlook: Navigating Growth and Strong Analyst Ratings in the Healthcare Sector

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture investor attention with its robust growth trajectory and favorable analyst ratings. With a staggering market..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Strong Revenue Growth and Promising Drug Pipeline Propel Investor Interest

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading biotechnology company based in Boston, continues to capture investor attention with its robust market position and innovative pharmaceutical developments. With a current market..

Elevance Health, Inc. (ELV) Stock Analysis: Riding a 12.12% Potential Upside with Strong Analyst Support

Elevance Health, Inc. (NYSE: ELV) stands as a formidable entity in the healthcare plans sector, boasting a substantial market capitalization of $86.86 billion. This Indianapolis-based company, formerly known as Anthem,..

The Cigna Group (CI) Stock Analysis: Unveiling a 23.03% Upside Potential

For investors keen on the healthcare sector, The Cigna Group (NYSE: CI) presents an intriguing opportunity with a potential upside of 23.03% based on the average target price of $341.42...

AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant with a 4.39% Upside Potential

AbbVie Inc. (ABBV), a powerhouse in the healthcare sector, continues to capture investor attention with its robust market presence and promising future prospects. With a market capitalization of $468.22 billion,..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 28.93% Upside Potential

AstraZeneca PLC (AZN), a leader in the healthcare sector, stands out in the general drug manufacturing industry with its impressive $257.42 billion market cap. As investors assess the company’s performance..

PPHE Hotel Group completes $33.5m sale of Manhattan development site

PPHE Hotel Group has completed the sale of its Manhattan development site for $33.5m, with proceeds to be allocated under its capital strategy...

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 79% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, specifically within the biotechnology industry, is making noticeable strides with its innovative suite of plasma-derived biologics. The company,..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Sector with a Market Cap of $4.26 Billion

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, operates within the specialized niche of medical devices. With a robust market capitalization of $4.26 billion, Integer Holdings..

iRhythm Holdings (IRTC) Stock Analysis: A 39.87% Upside Opportunity in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, thanks to its innovative approach to cardiac monitoring technology. With a market capitalization of $4.17 billion, this San..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: 94.70% Potential Upside Catches Investor Attention

Atrium Therapeutics, Inc. (NASDAQ: RNA) is generating buzz in the biotechnology sector, not only for its innovative approach to RNA-based therapies but also for its significant potential upside that has..

Search

Funds

US Broker Ratings

PPHE Hotel Group completes $33.5m sale of Manhattan development site

PPHE Hotel Group has completed the sale of its Manhattan development site for $33.5m, with proceeds to be allocated under its capital strategy...
Search

Funds

US Broker Ratings

FTSE 100

Funds